Intriguing data from Thessaloniki, Tubingen and Sheffield seem to lend more credence to normalizing methylcobalamin (Vitamin B12) in people with diabetic neuropathy. Aim: To investigate the effect of normalizing vitamin B12 (B12) levels with oral B12 (methylcobalamin) 1000 μg/day for one year in patients with diabetic neuropathy (DN). Patients and methods: In this prospective, double-blind, placebo-controlled trial,... Continue Reading →